Drug Discovery & Pharmaceuticals

RSS

EVQ-218: A Promising Candidate for Tackling Superbugs Without Triggering Antimicrobial Resistance

As the United Nations (UN) prepares to address the escalating threat of antimicrobial resistance, EVŌQ Nano is helping raise awareness through an educational infographic depicting a common trigger of antimicrobial resistance and highlighting EVQ-218's novel mechanism of action.

18 Oct 2024

Melanin May Act as a "Drug Sponge," Influencing Medication Effectiveness

Skin pigmentation may act as a "sponge" for some medications, potentially influencing the speed with which active drugs reach their intended targets, a pair of scientists report in a perspective article published in the journal Human Genomics.

15 Oct 2024

African Wormwood Identified as Potential Weapon Against Drug-Resistant Tuberculosis

The mechanisms through which A. afra fights M. tuberculosis.

14 Oct 2024

The Promise of Venomous Crustaceans in Drug Development

Many animals use venoms for self-defense or hunting. The components of such venom, known as toxins, interfere with various physiological processes - which is also the reason why they are so interesting for the development of new pharmacological agents.

7 Oct 2024

Fighting Drug-Resistant TB with a Novel Antibiotic

A novel semi-synthetic molecule that produces significant activity against strains of Mycobacterium tuberculosis, including those that are resistant to drugs, can be generated from natural compounds according to a study published in the American Society for Microbiology journal Microbiology Spectrum.

4 Oct 2024

Owlstone Medical and FDA Join Forces for Volatile Organic Compound Identification

Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has entered into a Research Collaboration Agreement with the FDA’s Center for Devices and Radiological Health (“CDRH”) - Office of Science and Engineering Laboratories (OSEL).

4 Oct 2024

New Quantum Algorithm Could Drastically Speed Up Drug Discovery

University of Copenhagen mathematicians have developed a recipe for upgrading quantum computers to simulate complex quantum systems, such as molecules. Their discovery brings us closer to being able to predict how new drugs will behave within our bodies and has the potential to revolutionize pharmaceutical development.

4 Oct 2024

Discovering New Drug Targets Through Paralog Hopping

Some proteins in the human body are easy to block with a drug; they have an obvious spot in their structure where a drug can fit, like a key in a lock. But other proteins are more difficult to target, with no clear drug-binding sites.

3 Oct 2024

New Task Force to Address Challenges in LGMD Research

A new task force entrusted with advancing therapeutic development for limb-girdle muscular dystrophies (LGMDs) has been formed by the Critical Path Institute (C-Path) under its Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®).

1 Oct 2024

High-throughput screening identifies potential drugs for low-grade serous ovarian cancer

In a recent study, researchers used high-throughput drug screening to identify potential therapeutic targets and novel treatments for low-grade serous ovarian cancer (LGSOC), offering hope for more effective and personalized therapies.

26 Sep 2024

Neutron Scattering Reveals Enzyme Secrets

Scientists have uncovered amazing information about the role of an enzyme that could assist in the development of drugs for aggressive cancers in just two neutron experiments.

25 Sep 2024

New study highlights the medicinal potential of plants consumed by gorillas

In a recent study, researchers examined the antibacterial and antioxidant properties of plants used by western lowland gorillas for self-medication, highlighting the potential of these bioactive compounds for therapeutic applications in human medicine.

19 Sep 2024

One-Third of Antibody Drugs Show Unintended Target Binding

Integral Molecular, a leader in antibody discovery and characterization, has published new research in the journal mAbs, revealing that as many as one-third of antibody-based drugs exhibit nonspecific binding to unintended targets.

18 Sep 2024

Monoclonal Antibody SC27 Shows Broad Effectiveness Against SARS-CoV-2 Variants

A monoclonal antibody appears effective at neutralizing the numerous variants of SARS-CoV-2, as well as related viruses in animals that could pose a threat if they were to begin spreading in people.

10 Sep 2024

Crystal Structure of i-Motif DNA Opens Doors for Targeted Drug Design

The first crystal structure of an alternative DNA shape from the insulin gene has been revealed by a UCL-led research team.

9 Sep 2024

ERS Genomics and Medicines Discovery Catapult Forge CRISPR Licensing Partnership

ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, and Medicines Discovery Catapult (‘MDC’), an independent, not-for-profit drug discovery innovation center, have signed a non-exclusive commercial-use CRISPR license agreement.

6 Sep 2024

Insights into Peptide Clumping Could Transform Drug Design and Material Science

Scientists from China have investigated how short peptide chains aggregate together in order to deepen our understanding of the process, which is crucial for drug stability and material development.

4 Sep 2024

New Advances in DEL Technology Facilitate Synthesis of Large, Complex Molecules

These days, remarkable new medical treatments are all the rage. One such treatment is personalized cancer therapy, which uses antibodies or immune cells that have been altered.

4 Sep 2024

RNA Interference Drugs Offer Faster, More Effective Alternative to Traditional Drug Discovery

Alnylam's RNA interference platform accelerates drug discovery by targeting RNA transcripts, addressing complex diseases with innovative therapeutic strategies.

28 Aug 2024

Cryo-EM Study Sheds Light on HSV Drug Resistance Mechanisms Through Protein Movement

All organisms -; from fungi to mammals -; have the capacity to evolve and adapt to their environments. But viruses are master shapeshifters with an ability to mutate greater than any other organism. As a result, they can evade treatments or acquire resistance to once-effective antiviral medications.

28 Aug 2024

Drug Discovery & Pharmaceuticals

EVQ-218: A Promising Candidate for Tackling Superbugs Without Triggering Antimicrobial Resistance

Melanin May Act as a "Drug Sponge," Influencing Medication Effectiveness

African Wormwood Identified as Potential Weapon Against Drug-Resistant Tuberculosis

The Promise of Venomous Crustaceans in Drug Development

Fighting Drug-Resistant TB with a Novel Antibiotic

Owlstone Medical and FDA Join Forces for Volatile Organic Compound Identification

New Quantum Algorithm Could Drastically Speed Up Drug Discovery

Discovering New Drug Targets Through Paralog Hopping

New Task Force to Address Challenges in LGMD Research

High-throughput screening identifies potential drugs for low-grade serous ovarian cancer

Neutron Scattering Reveals Enzyme Secrets

New study highlights the medicinal potential of plants consumed by gorillas

One-Third of Antibody Drugs Show Unintended Target Binding

Monoclonal Antibody SC27 Shows Broad Effectiveness Against SARS-CoV-2 Variants

Crystal Structure of i-Motif DNA Opens Doors for Targeted Drug Design

ERS Genomics and Medicines Discovery Catapult Forge CRISPR Licensing Partnership

Insights into Peptide Clumping Could Transform Drug Design and Material Science

New Advances in DEL Technology Facilitate Synthesis of Large, Complex Molecules

RNA Interference Drugs Offer Faster, More Effective Alternative to Traditional Drug Discovery

Cryo-EM Study Sheds Light on HSV Drug Resistance Mechanisms Through Protein Movement

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics